Pars No Tarkib

Pars No Tarkib is an Iranian biopharmaceutical company based in Tehran that specializes in the development and manufacturing of advanced therapeutic biologics. The company is best known for producing Pegaferon, a locally manufactured 40 kDa pegylated interferon alpha-2a used for the treatment of chronic hepatitis C. By providing a high-quality, cost-effective alternative to international brands such as Pegasys, Pars No Tarkib has significantly improved access to essential antiviral therapy within the Iranian healthcare system. The company maintains strong research collaborations with academic institutions, particularly the Tehran University of Medical Sciences, to conduct clinical trials and validate the safety and efficacy of its products. Pars No Tarkib continues to be a key player in the Iranian biotechnology sector, focusing on addressing unmet medical needs through local innovation and manufacturing.